Market Quick Take - December 14, 2020

Market Quick Take - December 14, 2020

Macro 6 minutes to read
John Hardy

Head of FX Strategy

Summary:  The week is getting off to a cautious start after a choppy session in the US on Friday and a more distinctly downbeat session in Europe. Looking ahead to the event risks this week, the Wednesday US FOMC meeting stands out as the key event risk, together with prospects for the US stimulus package, and whether the Brexit negotiations are leading anywhere after the two sides decided at the weekend to continue talking.


What is our trading focus?

  • Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) - the major US indices traded in choppy fashion on Friday, but managed to pull off the low for the day to close at almost unchanged levels. We continue to look at the 12,000 level and then the 11,500-600 area in the Nasdaq 100 as important technical areas if developments this week for some reason derail market sentiment, which has looked very stretched to the bullish side of late. For the broader S&P 500 index, note that Tesla shares will be added to this index next Monday. The downside levels of interest for this index start at 3,600 and stretch to 3,530-3,500 if a deeper sell-off sets in. Friday’s low was right on the 21-day moving average, currently near 3,628.

  • Disney (DIS:xnys) - Disney shares rocketed over 13% higher on Friday to close at an all-time high after the company reported a smaller than expected loss. Helping drive the share price higher, the company noted a huge growth in the subscriber base for its Disney+ subscriber offering, that it would be raising the price of that offering and the roadmap for a slate of new shows based on its Marvel and Star Wars products; the CEO said that 80% of future projects will go to Disney+ over theaters. Disney expects 230-260mn subscribers on Disney+ by 2024 most likely becoming the biggest paid video streaming service in the world.

  • AstraZeneca (AZN:xlon) and Alexion (ALXN:xnas) - AstraZeneca reported on Saturday that it is acquiring Alexion for $39bn in a deal in which Alexion shareholders get $60 per share in cash and 2.12 AstraZeneca shares per share which combined is a $175 per share offer or 45% above Friday’s close. The expectation is that the deal will close in Q3 next year highlighting the big regulatory hurdle of large acquisition in the already high concentrated (few companies dominate) health care sector. The deal is obviously a move from AstraZeneca to add growth and a rare disease drug portfolio to its existing business. The combined business will have FY21 revenue of $36.6b and EBITDA of $13.3bn.

  • Bitcoin rallied hard this weekend - rising above 19,000 as the focus remains on the 20,000 level that was almost reached at the beginning of this month. A number of stories announcing institutional-type investors showing increasing interest in Bitcoin could be the driver behind the rebound. For example, Massachusetts Mutual Life Insurance company has invested in Bitcoin to the tune of $100 million.

  • AUDUSD and EURUSD – the US dollar looks offered and was sharply lower versus the Aussie this week and AUDUSD impressively managed to stay elevated well above 0.7500 overnight despite a steep correction in the price of iron ore, Australia’s number one export. With the break above 0.7400 there, the focus has shifted to 0.8000+, barring some event that dampens sentiment hoping for a global recovery. EURUSD has yet to etch new highs after consolidating in a narrow range capped by the 1.2178 cycle high. Technically, as long as the recent break of the 1.2000 area holds, traders will continue to focus toward 1.2555 - the early 2018 high.

  • EURGBP and GBPUSD – sterling will continue to trade nervously until we understand whether the UK and EU are headed toward a deal. Sterling saw a solid relief rally overnight that was partially unwound, but there is significant two-way potential and traders should respect the risks. It seems unlikely that a comprehensive deal can be struck before the end of the year, with the “best” outcome for sterling perhaps some indication that the terms of trade will continue as during the transition period, with negotiations to continue on some key areas next year.

  • Gold (XAUUSD) starts the week being stuck in a $1825/oz to $1850/oz range with short-term charts pointing to a 2-3% move on a break in either direction. Continued focus this week on vaccine rollouts, the final FOMC meeting of 2021 on Wednesday and another attempt to get a U.S. relief bill agreed before Christmas. Total ETF holdings slipped again on Friday with sentiment hurt by the general and elevated level of risk appetite seen elsewhere.

  • Brent crude oil (OILUKFEB21) and WTI crude oil (OILUSJAN21) start the week bid in response to U.S. vaccine rollouts shortening the route to a recovery in fuel demand. In the Middle East a ship near Saudi Arabia was hit by an explosion highlighting the risk of disruptions. Oil is increasingly being viewed as the cheapest of all reflation assets and with this in mind, the prospect for increased investor appetite, together with a recovery in demand, could propel prices higher in 2021. With this outlook in mind the market views the pandemic as old news and ‘just’ a bump in the road. Monthly oil market reports from Opec today, IEA on Tuesday and OPEC+ JMMC on Wednesday.

  • Federal Reserve meeting, stimulus talks and Markit PMI figures to dictate sentiment in Treasuries this week (10YUSTNOTEMAR21). The bond market is looking at the Fed meeting this week and any insight that it may give about the bond purchases program. Right now, the Fed is purchasing bonds at a pace of $80 billion a month, and there are speculations that the central bank will look to increase purchases in the longer part of the yield curve in order to curb the rise in yields. Ten-year yields are already falling, and on Friday they broke the support line of the ascending wedge they were trading since august and they might be poised to fall further if a stimulus doesn’t get agreed upon and PMI figures are weaker amid a second wave of Covid-19 case.

  • Spanish 10-year yields closed Friday below zero (BONH1). European sovereigns rallied on Friday as the market was digesting the ECB meeting the day before. Spanish ten-year yields fell below zero and closed the day below that level. In the periphery now only Italy and Greece are offering positive yields.

  • Gilt yields continue to fall as uncertainty surround Brexit (FLGH1). Brexit talks are set to continue and there is no specific timeline this time around. Ten-year gilts are opening the week with a yield of 0.16%, and as uncertainty rise, they may continue to fall until they test the 0.1% benchmark bank rate.

What is going on?

  • The Commitment of Traders report (COT) covering futures positions and changes made by speculators in the week to December show continued strong vaccine and stimulus optimism led demand for risk. The dollar short against ten IMM currency futures and the Dollar Index reached $31 billion, a ten-week high. In commodities, continued profit taking across agriculture commodities and a big setback for natural gas offset gains in oil, fuel products and metals, both precious and industrials. Overall, the total speculative position of 2.3 million lots across 24 major futures markets is not far from the February 2017 record. More on www.analysis.saxo.

  • US election results to be made official today. The US electors will vote today to finalize the result of the US election, which will be closing off all official legal routes for US President Trump to continue challenging the result after the Supreme Court has rejected to hear recent cases advanced by Republicans. Some in the Republican leadership are beginning to call for unity and for the party to recognize the result of the election with their eye on maintaining discipline ahead of the two Georgian Senate run-off races scheduled for January 5.

  • Japan Q4 Tankan survey released overnight shows sentiment generally improved far more than expected. The Large Manufacturing Index reading rose to –10 from –27 and vs. -15 expected, while for large Non-manufacturing the reading was –5 vs. -12 previously and –7 expected. Similar improvements in sentiment were seen in smaller firms in both manufacturing and non-manufacturing.

What we are watching next?

  • Brexit situation – at the weekend, the two sides decided to continue signaling that negotiations are ongoing even if they remain far apart on key issues, though at this late stage, just over two weeks from the end of the official transition period, one wonders what can be accomplished. Sterling was a bit higher on the open today in early trading hours, but lost much of those gains. UK Prime Minister Boris Johnson said the UK “certainly won’t be walking away from the talks” but continued to signal that his country should prepare to trade on WTO terms.

  • FOMC meeting on Wednesday - this is one of the last major event risks of the year that could disrupt the market narrative. After recent disappointing US employment figures, some believe that the Fed will announce an extension of the maturity of its purchases with an eye to guiding long rates lower. So the “hawkish” outcome would be a Fed that keeps its guidance unchanged and instead harps on the need for a more powerful fiscal stimulus to bridge the gap to the post-Covid vaccine recovery.

  • US stimulus package status – we are reaching decision time soon on the US stimulus package after a recent emergency funding measure was passed to keep the US government funded this week. A bipartisan group is set to present two versions of a stimulus bill – one of $908 billion that includes $160 billion in state and local government aid spending, and one without those measures.

Economic Calendar Highlights for today (times GMT)

  • 0900 – Switzerland SNB weekly sight deposits
  • 1000 – Euro Zone Oct. Industrial Production
  • Noon – OPEC's Monthly Oil Market Report
  • 2000 – New Zealand Q4 Westpac Consumer Confidence
  • 0030 – Australia RBA Meeting Minutes
  • 0200 – China Nov. Industrial Production
  • 0200 – China Nov. Retail Sales

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Saxo Markets
Most of our staff in Singapore are working from home to help limit the spread of the coronavirus. We remain at your service on the details below. Thank you for your understanding.

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.